To better model the human immune experience, the investigators introduce additional microbial experiences to specific pathogen-free mice by way of 3 models.

Immunology Database and Analysis Portal2025-10-30 更新20

Phase I clinical trial dataset: naked DNA SARS-CoV-2 Omicron BA.2 booster vaccine Alveavax-v1.2 against Janssen Ad26.COV2.S comparator, NCT05844202

新冠DNA疫苗I期试验

疫苗免疫原性

Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (Alveavax-v1.2): Results of a first-in-human, open-label, active-controlled, randomized dose-finding study of intradermal and subcutaneous applica

NIAID Data Ecosystem00

Clinical Islet Transplantation Consortium (CITC)

移植临床研究

糖尿病治疗靶点

The CIT consortium conducted a total of 9 studies across North America (CIT02 through CIT08) and the Nordic region (CIT01). CIT08 was a long-term follow-up study for interested participants at the Nor

Immunology Database and Analysis Portal2025-10-30 更新30

Dataset from Phase IV Open Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-Mumps-Rubella (MMR) Vaccine When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

疫苗免疫原性

疫苗安全性监测

To evaluate the safety and immunogenicity of GSK Biologicals' live attenuated MMR vaccine (Priorix) in a local population in Singapore. The vaccine was administered as a single dose to healthy childre

NIAID Data Ecosystem10

Pre-Existing Human Antibody Repertoire

资源简介：

相关数据集